Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
Details for Australian Patent Application No. 2006261452 (hide)
International Classifications
Event Publications
31 January 2008 PCT application entered the National Phase
PCT publication WO2006/136169 Priority application(s): WO2006/136169
4 February 2010 Application Accepted
Published as AU-B-2006261452
20 May 2010 Opposition Lodged
Alphapharm Pty Ltd has lodged an opposition against H. Lundbeck A/S.
16 June 2011 Opposition Proceeding - Application Withdrawn
The opposition by Alphapharm Pty Ltd against H. Lundbeck A/S has been withdrawn.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006261472-Glucagon like peptide-1 receptor (GLP-1R) regulators, preparation methods and uses
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser